How to Proceed with Medical M&A and Hospital Succession: Timeline, Costs, and Points to Note

When considering business succession or M&A for medical institutions, many people wonder, “Where should I start?” and “What is the process?” In particular, the complex procedures unique to medical corporations and highly specialized elements such as medical fees and licenses are involved, making specialized knowledge essential. This article explains the overall picture from initial consultation for medical M&A to final closing, and post-succession integration (PMI), focusing on specific steps, timelines, and points to consider unique to the medical industry. We hope this will be helpful for clinic directors, medical corporation chairpersons, and tax accountants, accountants, and consultants in charge of medical succession to achieve smooth business succession.

Initial Stage of Medical M&A: Importance of Consultation and Information Disclosure

In M&A for medical institutions, especially for business succession of medical corporations and clinics, consulting with experts in the initial stage is extremely important. Compared to the option of “closing the clinic” that many medical corporations face, M&A is an option that allows the business to continue, contribute to regional healthcare, and potentially generate founder’s profit (transfer gains). However, issues unique to medical corporations, such as general meetings of members, board of directors meetings, changes in members, the presence or absence of equity stakes (equity or non-equity company), and the return of funds, differ significantly from general corporate M&A. Furthermore, factors such as the impact of medical fee revisions, maintenance and changes in facility standards, and the transfer of various licenses also affect the valuation and structure of M&A. For the selling side, understanding these complex factors, accurately grasping the situation of their own institution, and consulting with a trusted M&A advisor is the first step. Advisors create an environment where detailed information can be provided with peace of mind through anonymous consultations and the execution of Non-Disclosure Agreements (NDAs). In the initial consultation, it is also important to share the timing of the owner’s retirement, desired transfer conditions, the absence of a successor, and aspirations for business continuity, and to assess compatibility with the advisor.

※The above is a general comparison and varies depending on the individual situation.

Details of the M&A Process: From Due Diligence to Closing

After the initial consultation, if the intention for M&A is solidified, the process moves to more concrete steps. First, an NDA is signed, and the seller discloses detailed information such as financial statements for the past three fiscal years, medical practice records, staff composition, and a list of medical equipment. Based on this, the M&A advisor performs a preliminary valuation (preliminary assessment) and presents an estimated market price for the transfer. At this stage, the seller can objectively understand the value of their institution and obtain information for setting realistic transfer conditions.

Next, matching with potential acquirers is carried out using the M&A advisor’s network and database. Anonymous information of the seller is presented, and after signing an NDA with interested parties, detailed information disclosure proceeds. This process typically takes about 1 to 3 months. Once potential candidates are narrowed down, a top meeting is scheduled. Here, the acquirer’s management philosophy, treatment of staff, and policies for patient care are directly confirmed to assess compatibility with the seller’s institution. If both parties agree on the basic M&A policy after the meeting, a Letter of Intent (LOI) is signed. The LOI includes the estimated transfer price, M&A structure, exclusivity period, and confidentiality obligations, but it is generally not legally binding (except for certain clauses).

After signing the LOI, the process moves to one of the most crucial steps: Due Diligence (DD). The acquirer conducts a detailed investigation of the target medical institution across a wide range of fields, including finance, tax, legal, medical legal affairs, human resources, and business (medical practice content, facilities, equipment, IT systems, licenses, etc.). The results of this DD significantly impact the final transfer price and contract terms. For medical institutions in particular, issues such as errors or omissions in medical fee claims, past medical litigation, compliance with facility standards, and personal information protection systems are strictly checked. It is not uncommon for unexpected risks to emerge through DD. Therefore, the seller also needs to prepare for DD by organizing relevant documents.

Based on the DD results, negotiations and signing of the final M&A agreement (SPA: Sale and Purchase Agreement) proceed. The SPA details all terms of the M&A transaction, including the transfer price, payment method, representations and warranties, indemnification, and conditions for termination. For medical corporations, procedures under the Medical Corporation Act, such as changes in members (shareholders), appointment and dismissal of directors, and the return or increase of funds, must also be carried out in parallel. These procedures involve registration with the Legal Affairs Bureau and notifications to supervisory authorities, making collaboration with experts (lawyers, judicial scriveners, administrative scriveners, etc.) indispensable.

Post-Succession Integration (PMI) and Issues Specific to Medical Institutions

With the signing of the M&A agreement and the completion of related procedures, the M&A transaction reaches its final stage: closing. At this point, the transfer price is paid, and management control is transferred. However, M&A does not end with closing. Rather, the post-merger integration (PMI) process is a crucial phase that determines the success or failure of the M&A. Especially for medical institutions, which play a role as infrastructure supporting the health of regional residents, it is necessary to proceed with smooth integration while minimizing the impact on patients, staff, and the local community.

In the initial stage of PMI, the first step is to understand the differences in organizational culture and business processes between the two organizations and to concretize the integration plan. Key issues include the continuation of staff employment, unification of treatment and benefits, integration of medical fee billing systems, coordination of electronic medical record systems, and standardization of infection control manuals. Furthermore, clear agreements are required in advance regarding the degree of involvement of the seller’s management during the handover period and their activities after retirement (e.g., scope of non-compete obligations).

From a long-term perspective, it is important to formulate post-integration management strategies, optimize medical functions, improve profitability, and ensure consistency with regional healthcare plans. For example, strengthening cooperation with nearby medical institutions, expanding specialized outpatient services, and providing preventive medicine and health promotion services can be considered. It is also essential to establish a system that can quickly respond to changes in medical fee regulations and healthcare systems. M&A advisors and consultants aim to maximize the results of the M&A by providing ongoing support for PMI for a certain period after closing.

Tax and Legal Considerations in Medical M&A

In M&A for medical institutions, specialized tax and legal considerations are essential. In particular, taxes on capital gains, the return of funds and distribution to members (shareholders) in the case of medical corporations, and the treatment of consumption tax are significantly affected by the structure. For example, if a medical corporation undergoes business succession while maintaining its non-profit status, a substantial tax burden may arise depending on the valuation and distribution method of equity stakes. Furthermore, the treatment of business tax varies depending on the type of medical corporation (association or foundation) and its business activities. For the seller, it is important to choose the most advantageous structure, considering the future tax burden.

For the acquirer, the main issues include consumption tax related to M&A, property taxes, real estate acquisition taxes, and procedures for transferring licenses. In particular, the valuation of assets such as medical fee receivables, medical equipment, and buildings is closely examined during DD. In addition, regulations related to the establishment of medical corporations and applications for permits and notifications to various administrative agencies may be difficult for those without specialized knowledge to handle accurately.

At M&A Medical, our experienced team of experts supports the creation of smooth and optimal M&A structures for both sellers and buyers, taking into account complex legal regulations such as the Medical Corporation Act, tax laws, and company laws. We provide advice tailored to individual circumstances, such as measures to reduce capital gains tax, optimize business tax, and the tax implications of returning funds, and support you in proceeding with M&A with peace of mind.

M&A and business succession for medical institutions require specialized knowledge and experience. M&A Medical offers optimal succession plans tailored to your institution’s situation through free consultations. Please feel free to contact us first.